CVE-2025-53930

Public Exploit
WeGIA vulnerable to Stored Cross-Site Scripting (XSS) via endpoint 'adicionar_especie.php' parameter 'especie'

Description

WeGIA is an open source web manager with a focus on the Portuguese language and charitable institutions. A Stored Cross-Site Scripting (XSS) vulnerability was identified in the `adicionar_especie.php` endpoint of the WeGIA application prior to version 3.4.5. This vulnerability allows attackers to inject malicious scripts into the `especie` parameter. The injected scripts are stored on the server and executed automatically whenever the affected page is accessed by users, posing a significant security risk. Version 3.4.5 fixes the issue.

Category

6.4
CVSS
Severity: Medium
CVSS 4.0 •
CVSS 3.1 •
EPSS 0.03%
Vendor Advisory github.com
Affected: LabRedesCefetRJ WeGIA
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-53930?
CVE-2025-53930 has been scored as a medium severity vulnerability.
How to fix CVE-2025-53930?
To fix CVE-2025-53930, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-53930 being actively exploited in the wild?
It is possible that CVE-2025-53930 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-53930?
CVE-2025-53930 affects LabRedesCefetRJ WeGIA.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.